A community computational challenge to predict the activity of pairs of compounds

Scikit-learn: Machine Learning in Python

Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016

The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856

Gene selection for cancer classification using support vector machines

Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.-R., Cupissol, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802656 · Cited by 3,726

Circular binary segmentation for the analysis of array-based DNA copy number data

Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. H. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,304

Addiction to Oncogenes--the Achilles Heal of Cancer

Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,764

Wisdom of crowds for robust gene network inference

The DREAM5 Consortium, Marbach, D., Costello, J. C., Küffner, R., Vega, N. M., Prill, R. J., Camacho, D. M., Allison, K. R., Kellis, M., Collins, J. J., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2016 · Cited by 1,667

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

Bokemeyer, C., Bondarenko, I., Makhson, A. M., Hartmann, J. T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8397 · Cited by 1,646

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

Green, M. R., Monti, S., Rodig, S. J., Juszczyński, P., Currie, T., O'Donnell, E., Chapuy, B., Takeyama, K., Neuberg, D. S., Golub, T. R., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282780 · Cited by 1,320

The transcriptional network for mesenchymal transformation of brain tumours

Carro, M. S., Lim, W. K., Alvarez, M. J., Bollo, R. J., Zhao, X., Snyder, E. Y., Sulman, E. P., Anne, S. L., Doetsch, F. K., Colman, H., et al. (2009) · Nature · doi:10.1038/nature08712 · Cited by 1,268

Modeling polypharmacy side effects with graph convolutional networks

Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501

Next-Generation Machine Learning for Biological Networks

Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C., & Collins, J. J. (2018) · Cell · doi:10.1016/j.cell.2018.05.015 · Cited by 1,012

Drug combinations: a strategy to extend the life of antibiotics in the 21st century

Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 849

Network-based prediction of drug combinations

Cheng, F., Kovács, I. A., & Barabási, A.-Ĺ. (2019) · Nature Communications · doi:10.1038/s41467-019-09186-x · Cited by 819

Toward understanding and exploiting tumor heterogeneity

Alizadeh, A. A., Aranda, V., Bardelli, A., Blanpain, C., Bock, C., Borowski, C., Caldas, C., Califano, A., Doherty, M., Elsner, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3915 · Cited by 760

Machine learning for integrating data in biology and medicine: principles, practice, and opportunities

Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 668

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Menden, M. P., Wang, D. Y. Q., Mason, M. J., Szalai, B., Bulusu, K. C., Guan, Y., Yu, T. V., Kang, J., Jeon, M., Wolfinger, R. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09799-2 · Cited by 371

Elucidating Compound Mechanism of Action by Network Perturbation Analysis

Woo, J. H., Shimoni, Y., Yang, W. S., Subramaniam, P., Iyer, A., Nicoletti, P., Rodríguez Martínez, M., López, G., Mattioli, M., Realubit, R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.056 · Cited by 351

Independent Drug Action in Combination Therapy: Implications for Precision Oncology

Plana, D., Palmer, A. C., & Sorger, P. K. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0212 · Cited by 336

Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics

Goodspeed, A. E., Heiser, L. M., Gray, J. W., & Costello, J. C. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0189 · Cited by 288

Big data in basic and translational cancer research

Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254

Deep learning for drug response prediction in cancer

Baptista, D., Ferreira, P. G., & Rocha, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz171 · Cited by 243

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence

Fleury, H., Malaquin, N., Tu, V., Gilbert, S., Martinez, A., Olivier, M.-A., Sauriol, S. A., Communal, L., Leclerc-Desaulniers, K., Carmona, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10460-1 · Cited by 228

Computational network biology: Data, models, and applications

Liu, C., Ma, Y., Zhao, J., Nussinov, R., Zhang, Y., Cheng, F., & Zhang, Z. (2019) · Physics Reports · doi:10.1016/j.physrep.2019.12.004 · Cited by 230

Combinatorial strategies for combating invasive fungal infections

Spitzer, M., Robbins, N., & Wright, G. D. (2016) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 227

The recurrent architecture of tumour initiation, progression and drug sensitivity

Califano, A., & Alvarez, M. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.124 · Cited by 203

MatchMaker: A Deep Learning Framework for Drug Synergy Prediction

Kuru, H. İ., Taştan, Ö., & Çiçek, A. E. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3086702 · Cited by 192

Crowdsourcing biomedical research: leveraging communities as innovation engines

Sáez-Rodríguez, J., Costello, J. C., Friend, S. H., Kellen, M., Mangravite, L. M., Meyer, P., Norman, T., & Stolovitzky, G. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.69 · Cited by 173

Computational models for predicting drug responses in cancer research

Azuaje, F. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw065 · Cited by 59

Leveraging big data to transform target selection and drug discovery

Chen, B., & Butte, A. J. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.318 · Cited by 165

Machine learning in the prediction of cancer therapy

Rafique, R., Islam, S. M. R., & Kazi, J. U. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.003 · Cited by 156

Bioinformatics Approaches for Anti-cancer Drug Discovery

Li, K., Du, Y., Li, L., & Wei, D. (2019) · Current Drug Targets · doi:10.2174/1389450120666190923162203 · Cited by 145

Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics

Koromina, M., Pandi, M.-T., & Patrinos, G. P. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0151 · Cited by 140

An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression

Liu, C., Dong, W. G., Xiang, J., Ren, F., Huang, L., Lang, J., Tian, G., Li, Y., & Yang, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.003 · Cited by 138

Machine learning for perturbational single-cell omics

Ji, Y., Lotfollahi, M., Wolf, F. A., & Theis, F. J. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.016 · Cited by 137

High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds

Zampieri, M., Szappanos, B., Buchieri, M. V., Trauner, A., Piazza, I., Picotti, P., Gagneux, S., Borrell, S., Gicquel, B., Lelièvre, J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3973 · Cited by 134

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data

Guinney, J., Wang, T., Laajala, T. D., Winner, K. K., Bare, J. C., Neto, E. C., Khan, S. A., Peddinti, G., Airola, A., Pahikkala, T., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30560-5 · Cited by 143

Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer

Sun, Y., Sheng, Z., Ma, C., Tang, K., Zhu, R., Wu, Z., Shen, R., Feng, J. H., Wu, D., Huang, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9481 · Cited by 137

Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling

Flobak, Å., Baudot, A., Rémy, É., Thommesen, L., Thieffry, D., Kuiper, M. T. R., & Lægreid, A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004426 · Cited by 134

A survey of graph neural networks in various learning paradigms: methods, applications, and challenges

Waikhom, L., & Patgiri, R. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-022-10321-2 · Cited by 228

Harnessing synthetic lethality to predict the response to cancer treatment

Lee, J. S., Das, A., Jerby‐Arnon, L., Arafeh, R., Auslander, N., Davidson, M. A., McGarry, L., James, D. T., Amzallag, A., Park, S. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04647-1 · Cited by 122

Predicting tumor cell line response to drug pairs with deep learning

Xia, F., Shukla, M. P., Brettin, T. S., García–Cardona, C., Cohn, J. D., Allen, J., Maslov, S., Holbeck, S. L., Doroshow, J. H., Evrard, Y. A., et al. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2509-3 · Cited by 128

Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles

Li, X., Xu, Y., Cui, H. S., Huang, T., Wang, D., Lian, B., Li, W., Qin, G., Chen, L., & Xie, L. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.05.008 · Cited by 128

Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects

Julkunen, H., Cichońska, A., Gautam, P., Szedmák, S., Douat, J., Pahikkala, T., Aittokallio, T. A., & Rousu, J. (2020) · Nature Communications · doi:10.1038/s41467-020-19950-z · Cited by 124

Machine learning methods, databases and tools for drug combination prediction

Wu, L., Wen, Y., Leng, D., Zhang, Q., Dai, C., Wang, Z., Liu, Z., Yan, B., Zhang, Y., Wang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab355 · Cited by 132

Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis

Plaisier, C. L., O’Brien, S. A., Bernard, B. M., Reynolds, S. M., Simon, Z., Toledo, C. M., Ding, Y., Reiss, D. J., Paddison, P. J., & Baliga, N. S. (2016) · Cell Systems · doi:10.1016/j.cels.2016.06.006 · Cited by 118

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Fujiwara, N., Kubota, N., Crouchet, É., Koneru, B., Marquez, C. A., Jajoriya, A. K., Panda, G., Qian, T., Zhu, S., Goossens, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4474 · Cited by 126

Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning

Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M. M., Griffiths, E., Bellows, D. S., Wright, G. D., & Tyers, M. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.003 · Cited by 125

Artificial intelligence in drug combination therapy

Tsigelny, I. F. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby004 · Cited by 124

In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data

Celebi, R., Bear Don’t Walk, O., Movva, R., Alpsoy, S., & Dumontier, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-45236-6 · Cited by 120

Chemogenomics and orthology‐based design of antibiotic combination therapies

Chandrasekaran, S., Çakmak, M. Ç., Sahin, N., Yılancıoğlu, K., Kazan, H., Collins, J. J., & Cokol, M. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156777 · Cited by 117

Predictive approaches for drug combination discovery in cancer

Tonekaboni, S. A. M., Ghoraie, L. S., Manem, V. S., & Haibe‐Kains, B. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw104 · Cited by 118

Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction

Lin, X., Dai, L., Zhou, Y., Yu, Z., Zhang, W., Shi, J., Cao, D., Li, Z., Chen, H., Song, B., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad235 · Cited by 124

Combination therapeutics in complex diseases

He, B., Lu, C., Zheng, G., He, X., Wang, M., Chen, G., Zhang, G., & Lu, A. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12930 · Cited by 112

Additivity and Interactions in Ecotoxicity of Pollutant Mixtures: Some Patterns, Conclusions, and Open Questions

Rodea‐Palomares, I., González-Pleiter, M., Martín-Betancor, K., Rosal, R., & Fernández‐Piñas, F. (2015) · Toxics · doi:10.3390/toxics3040342 · Cited by 110

PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens

Bush, E. C., Ray, F., Alvarez, M. J., Realubit, R. B., Hai, L., Karan, C., Califano, A., & Sims, P. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00136-z · Cited by 100

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Xiong, Y., Guo, Y., Liu, Y., Wang, H., Gong, W., Liu, Y., Wang, X., Gao, Y., Yu, F., Su, D., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.06.009 · Cited by 104

Machine learning approaches for drug combination therapies

Paltun, B. G., Samuel Kaski, A., & Mamitsuka, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab293 · Cited by 108

Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs

El‐Hafeez, T. A., Shams, M. Y., Elshaier, Y. A. M. M., Farghaly, H. M., & Hassanien, A. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-52814-w · Cited by 105

Systems Pharmacology: Defining the Interactions of Drug Combinations

van Hasselt, J. G. C., & Iyengar, R. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021511 · Cited by 105

Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics

Sinkala, M., Mulder, N., & Martin, D. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-58290-2 · Cited by 100

Mining molecular structure databases: Identification of small molecules based on fragmentation mass spectrometry data

Hufsky, F., & Böcker, S. (2016) · Mass Spectrometry Reviews · doi:10.1002/mas.21489 · Cited by 102

Mapping the functional landscape of T cell receptor repertoires by single-T cell transcriptomics

Zhang, Z., Xiong, D., Wang, X., Liu, H., & Wang, T. (2021) · Nature Methods · doi:10.1038/s41592-020-01020-3 · Cited by 108

A Computational Approach for Identifying Synergistic Drug Combinations

Gayvert, K. M., Aly, O., Platt, J. T., Bosenberg, M., Stern, D. F., & Elemento, O. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005308 · Cited by 97

MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery

Wooten, D. J., Meyer, C. T., Lubbock, A. L. R., Quaranta, V., & Lopez, C. F. (2021) · Nature Communications · doi:10.1038/s41467-021-24789-z · Cited by 97

Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling

Niepel, M., Hafner, M. A., Duan, Q., Wang, Z., Paull, E., Chung, M., Lü, X., Stuart, J. M., Golub, T. R., Subramanian, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01383-w · Cited by 93

A New View of Pathway-Driven Drug Resistance in Tumor Proliferation

Nussinov, R., Tsai, C., & Jang, H. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.02.001 · Cited by 94

Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery

Ravikumar, B., & Aittokallio, T. A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1413089 · Cited by 101

Anticancer drug synergy prediction in understudied tissues using transfer learning

Kim, Y., Zheng, S., Tang, J. P., Zheng, W. J., Li, Z., & Jiang, X. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa212 · Cited by 90

A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities

Narayan, R. S., Molenaar, P., Teng, J., Cornelissen, F. M. G., Roelofs, I., de Menezes, R. X., Dik, R., Lagerweij, T., Broersma, Y., Petersen, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16735-2 · Cited by 89

Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis

Peterson, E. J. R., Ma, S., Sherman, D. R., & Baliga, N. S. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.78 · Cited by 84

Boolean network modeling in systems pharmacology

Bloomingdale, P., Nguyen, V. A., Niu, J., & Mager, D. E. (2018) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9567-4 · Cited by 86

Systems medicine: evolution of systems biology from bench to bedside

Wang, R., Maron, B. A., & Loscalzo, J. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1297 · Cited by 82

In silico drug combination discovery for personalized cancer therapy

Jeon, M., Kim, S., Park, S., Lee, H., & Kang, J. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0546-1 · Cited by 81

Charting the Fragmented Landscape of Drug Synergy

Meyer, C. T., Wooten, D. J., Lopez, C. F., & Quaranta, V. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.011 · Cited by 79

Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies

Campos, A. I., & Zampieri, M. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.001 · Cited by 79

Deep learning of pharmacogenomics resources: moving towards precision oncology

Chiu, Y., Chen, H.-I. H., Gorthi, A., Mostavi, M., Zheng, S., Huang, Y., & Chen, Y. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz144 · Cited by 80

Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients

He, L., Tang, J. P., Andersson, E. I., Timonen, S., Koschmieder, S., Wennerberg, K., Mustjoki, S. M., & Aittokallio, T. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3644 · Cited by 77

Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction

Huang, L. F., Brunell, D. J., STEPHAN, C. C., Mancuso, J. J., Yu, X., He, B., Thompson, T. C., Zinner, R., Kim, J., Davies, P. J., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz109 · Cited by 72

Drug-Drug Adverse Effect Prediction with Graph Co-AttentionPreprint

Deac, A., Huang, Y.-H. J., Veličković, P., Lió, P., & Tang, J. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1905.00534 · Cited by 104

A community challenge for a pancancer drug mechanism of action inference from perturbational profile data

Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100492 · Cited by 68

Multi-Relational Contrastive Learning Graph Neural Network for Drug-Drug Interaction Event Prediction

Xiong, Z., Liu, S., Huang, F., Wang, Z., Liu, X., Zhang, Z. M., & Zhang, W. (2023) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v37i4.25665 · Cited by 68

A review of machine learning approaches for drug synergy prediction in cancer

Torkamannia, A., Omidi, Y., & Ferdousi, R. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac075 · Cited by 66

MDDI-SCL: predicting multi-type drug-drug interactions via supervised contrastive learning

Lin, S., Chen, W., Chen, G., Zhou, S., Wei, D., & Xiong, Y. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00659-8 · Cited by 68

Drug Combinations: Mathematical Modeling and Networking Methods

Vakil, V., & Trappe, W. K. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050208 · Cited by 61

KekuleScope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images

Cortés‐Ciriano, I., & Bender, A. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0364-5 · Cited by 63

Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes

Regan, K., Xu, J., DiVincenzo, M. J., Duggan, M. C., Shakya, R., Na, R., Carson, W. E., Payne, P., & Li, F. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0085-4 · Cited by 62

SmileGNN: Drug–Drug Interaction Prediction Based on the SMILES and Graph Neural Network

Han, X., Xie, R., Li, X., & Li, J. (2022) · Life · doi:10.3390/life12020319 · Cited by 58

DeepDrug: A general graph‐based deep learning framework for drug‐drug interactions and drug‐target interactions prediction

Yin, Q., Cao, X., Fan, R., Liu, Q., Jiang, R., & Zeng, W. (2023) · Quantitative Biology · doi:10.15302/j-qb-022-0320 · Cited by 63

Advances in systems biology modeling: 10 years of crowdsourcing DREAM challenges

Meyer, P., & Sáez-Rodríguez, J. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.015 · Cited by 57

Stratification and prediction of drug synergy based on target functional similarity

Yang, M., Jaaks, P., Dry, J. R., Garnett, M. J., Menden, M. P., & Sáez-Rodríguez, J. (2020) · npj Systems Biology and Applications · doi:10.1038/s41540-020-0136-x · Cited by 54

Synthetic Lethality in Cancer Therapeutics

Beijersbergen, R. L., Wessels, L. F. A., & Bernards, R. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042016-073434 · Cited by 56

Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infection

Noh, H., Shoemaker, J. E., & Gunawan, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1314 · Cited by 50

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K. C., Siddiquee, A., You, D., Realubit, R., et al. (2021) · doi:10.1101/2021.10.03.462951 · Cited by 51

Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence

Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50

Advances in computational approaches in identifying synergistic drug combinations

Sheng, Z., Sun, Y., Yin, Z., Tang, K., & Cao, Z. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx047 · Cited by 50

Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

Lafontaine, J., Cardin, G. B., Malaquin, N., Boisvert, J.-S., Rodier, F., & Wong, P. (2021) · Cancers · doi:10.3390/cancers13030386 · Cited by 54

DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions

Kim, E., & Nam, H. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00589-5 · Cited by 51

MARSY: a multitask deep-learning framework for prediction of drug combination synergy scores

Khili, M. R. E., Memon, S. A., & Emad, A. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad177 · Cited by 49

Statistical Hypothesis Testing versus Machine Learning Binary Classification: Distinctions and Guidelines

Li, J. J., & Tong, X. (2020) · Patterns · doi:10.1016/j.patter.2020.100115 · Cited by 57

StratMed: Relevance stratification between biomedical entities for sparsity on medication recommendation

Li, X., Liang, S., Hou, Y., & Ma, T. (2023) · Knowledge-Based Systems · doi:10.1016/j.knosys.2023.111239 · Cited by 44

Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures

Mason, D. J., Eastman, R. T., Lewis, R. P. I., Stott, I. P., Guha, R., & Bender, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01096 · Cited by 43

Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment

Cokol, M., Li, C., & Chandrasekaran, S. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006677 · Cited by 43

DeepInsight-3D architecture for anti-cancer drug response prediction with deep-learning on multi-omics

Sharma, A. K., Lysenko, A., Boroevich, K. A., & Tsunoda, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-29644-3 · Cited by 43

SYNDEEP: a deep learning approach for the prediction of cancer drugs synergy

Torkamannia, A., Omidi, Y., & Ferdousi, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33271-3 · Cited by 41

Predicting ligand-dependent tumors from multi-dimensional signaling features

Hass, H., Masson, K., Wohlgemuth, S., Paragas, V. B., Allen, J. E., Sevecka, M., Pace, E. A., Timmer, J., Stelling, J., MacBeath, G., et al. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0030-3 · Cited by 43

Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data

Sorokin, M., Kholodenko, R. V., Suntsova, M., Malakhova, G., Garazha, A., Kholodenko, I. V., Poddubskaya, E. V., Lantsov, D., Stilidi, I. S., Arhiri, P. P., et al. (2018) · Cancers · doi:10.3390/cancers10100365 · Cited by 40

The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies

Diaz, J. E. L., Ahsen, M. E., Schaffter, T., Chen, X., Realubit, R. B., Karan, C., Califano, A., Losic, B., & Stolovitzky, G. A. (2020) · eLife · doi:10.7554/elife.52707 · Cited by 38

Graph Neural Networks: Methods, Applications, and OpportunitiesPreprint

Waikhom, L., & Patgiri, R. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2108.10733 · Cited by 40

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Menden, M. P., Wang, D., Mason, M. J., Szalai, B., Bulusu, K. C., Guan, Y., Yu, T., Kang, J., Jeon, M., Wolfinger, R., et al. (2019) · Greater South Information System · doi:10.60692/3f1af-xf873

Predicting synergistic effects between compounds through their structural similarity and effects on transcriptomes

Liu, Y., & Zhao, H. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw509 · Cited by 38

A simple gene set-based method accurately predicts the synergy of drug pairs

Hsu, Y.-C., Chiu, Y., Chen, Y., Hsiao, T.-H., & Chuang, E. Y.-Y. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0310-3 · Cited by 16

DIGREM: an integrated web-based platform for detecting effective multi-drug combinations

Zhang, M., Lee, S., Yao, B., Xiao, G., Xu, L., & Xie, Y. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty860 · Cited by 9

MatchMaker: A Deep Learning Framework for Drug Synergy Prediction

Kuru, H. İ., Taştan, Ö., & Çiçek, A. E. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3086702 · Cited by 192